Clinical Trial: Low-Dose Radiotherapy Combined with Retilrafusp alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma (China)

China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Low-Dose Radiotherapy Combined with Retilrafusp alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133477

Registration Time: 2026/09/28

Type: Interventional study

Primary Sponsor: harbin medical university cancer hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345501

Published by HT Digital Content Services with permission from Health Daily Digest....